Literature DB >> 11798758

[Vascular lesion and its mechanisms in spleen under statement of portal hypertension].

B Shi1, Z Yang.   

Abstract

OBJECTIVE: To investigate the vascular lesion and its mechanisms in spleen in patients with portal hypertension.
METHODS: 28 specimens of spleen from portal hypertension patients and 10 from normal controls were stained by HE and Masson Trichrome to study their vascular pathological lesions. The proteins of PCNA, and Flt-1 were analyzed by immunohistochemistry. The mRNAs of VEGF and bFGF were also identified with in situ hybridization.
RESULTS: Various vascular lesions occurred, such as sclerosis endangitis fibrosis and endothelial cell damage. The proteins of PCNA, and Flt-1 were intensively immunostained in portal hypertension spleens compared with normal controls. The mRNAs of VEGF and bFGF were highly expressed, but weakly in controls.
CONCLUSIONS: (1) Vascular lesion of spleen is one part of portal hypertensive vascular lesions. (2) The mechanisms of these lesions are due to the changes of microcirculation and hemodynamics, immune disorders, increasing growth factors such as VEGF, Flt-1 and bFGF both at protein and transcription levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11798758

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  2 in total

1.  Changes in count and function of splenic lymphocytes from patients with portal hypertension.

Authors:  Zong-Fang Li; Shu Zhang; Gao-Bo Lv; Ying Huang; Wei Zhang; Song Ren; Jun Yang; Shuang-Suo Dang
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

2.  Expression of local renin and angiotensinogen mRNA in cirrhotic portal hypertensive patient.

Authors:  Li Zhang; Zhen Yang; Bao-Min Shi; Da-Peng Li; Chong-Yun Fang; Fa-Zu Qiu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.